Summary The incidence, mortality and survival of breast cancer patients from 1970 to 1993 were studied using data from the Cancer Registry of Norway. The age-adjusted incidence rate increased from 62.0 to 76.9 per 100 000 person-years during the period, and more than 2000 cases are now registered annually. The increase tends to be highest in the age group below 40 years. The increase is mainly found in cases with localized tumours at the time of diagnosis. The mortality rate has been almost unchanged in the period; the age adjusted mortality rate is 27.0 per 100 000 person-years at the end of the study period. The 5-year overall survival has increased among cases with axillary lymph node metastases at the time of diagnosis; the other stages show only little improvement. Keywords: breast cancer; incidence; stage distribution; mortality; trends In 1985, the worldwide incidence of breast cancer was estimated to be 720 000 new cases per year, 422 000 in developed countries and 298 000 in developing countries (Parkin et al, 1993). Breast cancer was third in frequency when both sexes were considered together and by far the most important cancer in women (19% of the diagnosis). The incidence rates are increasing in all countries with available statistics, and its impact is magnified because women are at risk from their late thirties. The incidence rates of breast cancer are in general much higher in developed countries than in developing countries; the highest incidence rates are found in North America. In Norway, breast cancer contributed 22.4% of female cancer diagnosis in 1993 (The Cancer Registry of Norway, 1996). Although several risk factors are known, the understanding of breast cancer aetiology is limited. Most of the known risk factors are associated with less than a twofold increase in risk, and breast cancer development is probably a process in which several factors act together.
In 1985, the worldwide incidence of breast cancer was estimated to be 720 000 new cases per year, 422 000 in developed countries and 298 000 in developing countries (Parkin et al, 1993) . Breast cancer was third in frequency when both sexes were considered together and by far the most important cancer in women (19% of the diagnosis). The incidence rates are increasing in all countries with available statistics, and its impact is magnified because women are at risk from their late thirties. The incidence rates of breast cancer are in general much higher in developed countries than in developing countries; the highest incidence rates are found in North America. In Norway, breast cancer contributed 22.4% of female cancer diagnosis in 1993 (The Cancer Registry of Norway, 1996) . Although several risk factors are known, the understanding of breast cancer aetiology is limited. Most of the known risk factors are associated with less than a twofold increase in risk, and breast cancer development is probably a process in which several factors act together.
Mortality rates have generally been increasing worldwide, but the increase is now reported to have declined in several western countries (Hermon and Beral, 1996) . This may be explained by earlier detection, better treatment regimes or less aggressive biological behaviour of the tumours. Studies have shown significant mortality reduction by routine mammographic examination of women aged 50-69 years (Nystr0m et al, 1993) . Thus, screening programmes have been organized in several European countries. The aim of this study is to describe and analyse the trends of breast cancer incidence in Norway in different age groups and stages together with mortality trends and 5-year relative survival. A large screening project was recently (1996) started in Norway among women aged 50-69 years. It is therefore of interest to analyse breast cancer data in Norway before organized screening was started. A multivariate analysis of the 5-year survival was conducted using a model described by Hakulinen and Tenkanen (1987) . To have enough data in all groups in this analysis, the youngest age group was defined as 0-39 years. The model was fitted using the GLIM 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993 Period of diagnosis Figure 1 Age-adjusted incidence (-+-) and mortality (--a-) rates in Norway 1970 Norway -1993 Norway 1970 Norway -1974 Norway 1975 Norway -1979 Norway 1980 Norway -1984 Norway 1985 Norway -1989 Norway 1990 Norway -1993 Period of diagnosis 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993 British Journal of Cancer (1998) 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993 The urban/rural status is defined by 'Statistics Norway' on the basis of administrative areas. The difference between urban and rural incidence and mortality rates was analysed by dividing the study period into two periods: 1970-1981 and 1982-1993 .
MATERIALS AND METHODS
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RESULTS Incidence
The age-adjusted incidence and mortality curves are shown in Figure 1 . The average annual number of breast cancer cases increased from 1309 in the period 1970-1974 to 1932 in the period 1990-1993, a 47% increase (Table 1) . There is an increasing incidence rate in all age groups during the whole study period. The annual age-adjusted increase in the incidence rate is estimated at 1.0% (Table 1) . The increase tends to be higher in the youngest (< 40 years) and oldest (> 70 years) age groups. In the latest decade (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) , the annual increases were estimated to be 3.3%, 2.7% and 2.2% for the age groups 0-29, 30-39 and 40-49 years respectively (data not shown).
Stage-specific incidence rates by period are illustrated in Figure  2 , and absolute numbers are presented in Table 2 . Table 3 presents the proportion of tumours at different stages and ages in the periods 1970-1974 and 1990-1993 The urban/rural analysis reveals that the age-adjusted relative incidence rate tends to be almost unchanged, with an urban dominance decreasing only from 1.21 to 1.16. Among women below 40 years, there was no difference in urban/rural incidence rates in 1982-1993, indicating that the increase in incidence has been higher in rural than in urban areas.
Mortality
The age-adjusted mortality rate is practically unchanged during the study period (Figure 1) , with an estimated yearly increase of 0.5%. There is a small reduction in the age group 50-59 years (-0.6%), whereas the mortality rates increase most among women above 80 years (1.6%) ( Table 4 ). The urban/rural analysis (data not shown) reveals that the relative mortality rate tends to be almost unchanged, with an urban dominance decreasing from 1.17 to 1.10. Among women under 60 years, no difference was found in urban/rural incidence rates in 1982-1993.
Survival
The 5-year relative survival rates by age and stage in the two periods 1970-1974 and 1985-1989 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993 were subjected to an analysis of incidence, mortality and survival. The completeness of the Cancer Registry data, both on diagnosis and on cause of death, make the data reliable. The main finding in this study is the increasing incidence rate during the whole study period, estimated to be 1.0% yearly. Estimates of annual increase are higher for the last decade than for the whole study period. Increasing incidence rates are reported in Denmark and Iceland before organized mammography screening (Andreasen et al, 1994; Sigurdsson et al, 1991) . Some studies from the USA (Newcomb and Lantz, 1993; Garfinkel et al, 1994) show declining incidence rates since the late 1980s after several years of increasing incidence. This is probably due to more years of extended use of mammography in asymptomatic women. Norway, however, has had no organized screening programme for breast cancer during the study period. Still, the yearly number of mammograms taken unorganized in Norway has increased from 10 000 in 1983 to 220 000 in 1993 (Widmark and Olsen, 1995) . Most of these mammograms were taken among younger women (therefore at lower risk) living in urban areas. We found that incidence rates are increasing in all age groups, but the increase is most pronounced among women younger than 40 years. As the increase in these age groups is highest in rural areas, this increase is probably not caused by extended use of mammography. A similar trend in incidence among women younger than 40 was not found in Sweden (Persson et al, 1998 ), but our results confirm a previous report on incidence increase among Norwegian women under 50 years in the period [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] (Matheson and Tretli, 1996) . A transient incidence increase reported among Swedish women aged 50-69 years is most probably the result of mammographic screening (Persson et al, 1998 ). It will be interesting to see if the ongoing Norwegian screening project will cause a similar transient incidence increase among women aged 50-69 years. A Danish study (Andreasen et al, 1994) , before mammographic screening, reports that the largest increase in incidence was found among women younger than 60 years. In some countries of low incidence, such as Japan, the rise in incidence has so far been observed predominantly in women under the age of 50 years and appears to be a birth cohort effect (Miller and Bulbrook, 1986) . Lower breast cancer incidence rates than expected are reported among Norwegian women who experienced their adolescence during World War II (Tretli and Gaard, 1996) . This birth cohort effect implies that one or more lifestyle factors that changed among adolescent women during the war influenced their risk of breast cancer. There is an increasing awareness of the importance of the period between menarche and first birth (Colditz and Frazier, 1995) . Factors such as adolescence nutrition (Tretli and Gaard, 1996) and regular physical exercise (Bernstein et al, 1994) are thought to have an impact on later risk of developing breast cancer, but more studies are required on the possible impact of teenage lifestyle on breast cancer risk.
Attention has focused an environmental and dietary oestrogens as possible contributors to the increased incidence of breast cancer but the epidemiological findings are inconclusive (Ahlborg et al, 1995; Safe, 1995) . However, even though the total amount of environmental and dietary oestrogen is low, it might have an influence over time, especially in adolescent women. It is well known that a woman's reproductive history affects her risk of breast cancer (Kv'ale et al, 1987; . The delayed child-bearing pattern that is seen in most western countries is another factor that may contribute to a woman's total risk of developing breast cancer. These factors may be contributors to the observed increase in incidence rates among younger women. It is interesting to notice that the difference between urban and rural areas is decreasing and, among younger women, no difference in incidence rate is found in the latest period. This may be explained by the fact that rural lifestyle, including nutrition, has changed towards that in urban areas.
Our data reveal an excess increase in incidence rates among older women (above 70 years). This may be explained by an increasing proportion of very elderly women together with increased breast cancer awareness. The increase in incidence in stage 1 diagnosis is especially high in this age group, but this is probably an artifact caused by less extensive examination of axillary lymph nodes among older patients.
The role of stage 1 diagnosis is increasing (Figure 2 and Table  3 ). There may be several reasons for this increase in stage 1 diagnosis, for instance early detection or change in tumour biology. Mammography of asymptomatic women is a method that causes stage migration towards stage 1, but in Norway most women detect their breast cancer themselves. The increased breast cancer awareness in general and instruction in self-palpation have caused women to visit their doctor earlier, thus getting their diagnosis at a stage with better prognosis. It is likely, however, that as a result of the ongoing large screening project, the part of stage 1 diagnosis will continue to increase in the age group 50-69 years. One may speculate that change in some environmental factors initiates tumour development more easily than before, but that the tumours are less aggressive and remain longer in stage 1. A tendency for oral contraceptive users to have more localized tumours than never users has been reported (Collaborative group on Hormonal Factors in Breast Cancer, 1996) and perhaps other factors such as xenooestrogens have a similar effect.
The possibility has been raised that lesions that would remain benign are now being diagnosed and treated as cancer. If so, we would have expected a more pronounced improvement in 5-year survival among the stage 1 cases. It is, therefore, more likely that the cases diagnosed would develop into stages with poorer prognosis if not treated properly.
We find that the mortality rate is practically unchanged in the study period. It is interesting to note that the Scandinavian countries (which all have complete cancer registers) report different mortality trends. Denmark reports an unchanged mortality rate, as in this study (Ewertz and Carstensen, 1988) . In Finland, the mortality was increasing until 1985, whereas Sweden has had a small decline since 1975 (Hermon and Beral, 1996) . It is difficult to explain which differences in lifestyle or health system might cause these different mortality trends, although nutrition and use of mammography could be among relevant factors.
As expected, stage at time of diagnosis is found to be the most important factor influencing the relative risk of death within 5 years. The multivariable analysis shows that this risk has significantly reduced during the study period by 20% (Table 6) , indicating better survival especially in stage 2, probably as a result of better treatment. This is also reflected in the 5-year survival rates in Table 5 . In the 1970s, surgery and radiation were the main treatment regimes, whereas chemotherapy has played a larger role in recent years. The use of such treatment and hormones have probably had a positive impact on survival. Sigurdsson K, Adalsson S and Ragnarsson J (1991) 
